PHARMACY

CVS Health is providing Massachusetts residents with on-the-spot COVID-19 testing and results at no cost, using the new Abbott ID NOW COVID-19 test.

Sandoz will continue to operate its oral solids and dermatology business as part of the Sandoz U.S. business.

CVS Health's rapid COVID-19 drive-through testing sites in Georgia, and Rhode Island will provide on the spot test results, while its pop-up pharmacy in New Orleans will provide maintenance medication and counseling for certain COVID-19 patients.

Innovation co-president Marvin Richardson takes over as CEO on April 25, succeeding Mary Reno, and co-president Tom Boyer will become chief strategy officer.

CVS Pharmacy field leaders and managers will select local organizations to receive donations.

A new Indiana law allows a pharmacist to substitute a therapeutic alternative for epinephrine products.

Aurobindo's generic Zanaflex will be available in three dosage strengths.

Mycophenolic acid delayed-release tablets had a market value of roughly $156 million, according to IQVIA data from February.

According to a survey commissioned by NACDS, 86% of voters say pharmacists should be allowed to provide tests for COVID-19, and the same number say pharmacists should be able to administer a vaccine once developed.

CVS Pharmacy announced new employee benefits and safety measures to keep employees and customers safe during the COVID-19 pandemic.

Vyepti is the first and only intravenous treatment for migraine prevention.